Abliva AB (EM)【NEVPF】銘柄情報

Abliva AB (EM) (NEVPF) 銘柄情報

リアルタイムのストリーミング引用、アイデア、ライブディスカッションのハブ

プレミアム

通貨

0.028

( - )

買値

0.00

売値

0.00

出来高

0.00 日の範囲 0.00

0.00 52 週間の範囲 0.00

時価総額

45.133M

前日終値

0.028

始値

時刻

最終取引時間

財務取引量

VWAP

平均取引量 (3 か月)

US$ 0

発行済株式数

1,611,884,536

配当利回り

PER

-6.67

1 株当たり利益 (EPS)

-0.07

歳入

純利益

-89.95M

Abliva AB (publ) develops medicines for the treatment of mitochondrial diseases. The company maintains a portfolio that includes projects at various stages, from early discovery to clinical phase. Its lead candidate, KL1333, targets fatigue and muscle weakness in adult patients with genetically conf... Abliva AB (publ) develops medicines for the treatment of mitochondrial diseases. The company maintains a portfolio that includes projects at various stages, from early discovery to clinical phase. Its lead candidate, KL1333, targets fatigue and muscle weakness in adult patients with genetically confirmed primary mitochondrial disease. Another product, NV354, uses prodrug technology to deliver succinate to cells for conditions such as Leigh syndrome, while NV556 is evaluated as a cyclophilin inhibitor for liver fibrosis and hepatocellular carcinoma. The company conducts research and development focused on the regulation and stabilization of cellular energy production and collaborates with patient organizations as part of its development approach. The company was founded in 2000 and is based in Lund, Sweden. 詳細を表示

セクター

Finance

業界

Asset Management Services

ウェブサイト

abliva.com

本社

Lund, Sweden

設立

2026

Abliva AB (EM) is listed in the Finance sector of the その他OTC with ticker NEVPF. The last closing price for Abliva AB (EM) was US$0.03. Over the last year, Abliva AB (EM) shares have traded in a share price range of US$ 0.00 to US$ 0.00.

Abliva AB (EM) currently has 1,611,884,536 shares in issue. The market capitalisation of Abliva AB (EM) is US$45.13 million. Abliva AB (EM) has a price to earnings ratio (PE ratio) of -6.67.

表示するニュースはありません。